ZEALAND PHARMA AS DKK1 revenue breakdown overview

ZEALAND PHARMA AS DKK1 revenue for the last year amounted to 342.80 M DKK, the most of which — 342.79 M DKK — came from its highest performing source at the moment, Peptide-based Medicines, the year earlier bringing 103.99 M DKK. The greatest contribution to the revenue figure was made by Germany — last year it brought ZEALAND PHARMA AS DKK1 294.51 B DKK.